Safety Medical Products (ASX:SFP) has now executed a formal Share Sale Agreement to acquire 3D Medical Limited.
3D Medical is an emerging service provider that will offer the healthcare sector a suite of technologies that leverage 3D volumetric data.
The company is focussed on four technologies that have the potential to revolutionise diagnosis and patient treatment by providing healthcare professionals greater insight into patient anatomy.
The platform technologies that 3D Medical intends to pursue include a 3D printing service to create tactile, anatomical models; and holographic projection via partnership with Echopixel Inc.
The Share Sale Agreement is binding, subject to satisfaction or waiver of conditions precedent including re-compliance with Chapters 1 and 2 of the ASX Listing Rules.
The transaction will include an equity raising of at least $2,000,000 to provide funding for the 3D Medical business and general working capital.
The SSA replaces the Heads of Agreement that was executed on 19 June 2014.
SFP is to acquire 3D Medical for 1,750,000,000 SFP consideration shares; 43,750,000 advisory shares; and 875,000,000 options.
